» Authors » L De Marinis

L De Marinis

Explore the profile of L De Marinis including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 154
Citations 1048
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Cannavo S, Bogazzi F, Colao A, De Marinis L, Maffei P, Gomez R, et al.
J Endocrinol Invest . 2015 Apr; 38(10):1099-109. PMID: 25916431
Objective: GH receptor antagonist pegvisomant is indicated for treatment of patients with resistant acromegaly. We compared safety and treatment outcomes of pegvisomant therapy in patients managed by Italian centers enrolling...
12.
Giustina A, Ambrosio M, Beck Peccoz P, Bogazzi F, Cannavo S, De Marinis L, et al.
J Endocrinol Invest . 2014 Sep; 37(10):1017-30. PMID: 25245336
No abstract available.
13.
Grottoli S, Maffei P, Bogazzi F, Cannavo S, Colao A, Ghigo E, et al.
Endocrine . 2014 Aug; 48(1):334-41. PMID: 25150035
ACROSTUDY is a world-wide non-interventional, post marketing surveillance study performed to monitor the safety and outcomes of pegvisomant (PEG) in clinical practice. We report data from acromegaly patients who have...
14.
Iacovazzo D, De Marinis L
Endocrine . 2014 Aug; 48(1):76-8. PMID: 25112228
The incidence of hyperprolactinemia in women peaks during the 3rd-4th decade and then greatly decreases after the menopause. Apart from the effects on the hypothalamic-pituitary-gonadal axis, prolactin can act directly...
15.
Mazziotti G, Mormando M, Cristiano A, Bianchi A, Porcelli T, Giampietro A, et al.
Eur J Endocrinol . 2014 May; 170(6):893-9. PMID: 24836549
Objective: In this study, we aimed at evaluating the association between radiological vertebral fractures and levo-thyroxine (l-T4) replacement doses in adult patients with hypopituitarism. Design: Cross-sectional study. Methods: We studied...
16.
Pierconti F, Milardi D, Martini M, Grande G, Cenci T, Gulino G, et al.
Andrologia . 2014 Apr; 47(4):427-32. PMID: 24754453
Genomic instability is a feature of germ cell tumours. The pituitary-tumour-transforming-gene 1 (PTTG1) is the major effector of chromosome segregation during mitosis, protecting the cell from aneuploidy. The protein expression...
17.
Iacovazzo D, Lugli F, Piacentini S, Bianchi A, Inzani F, Larocca L, et al.
Endocrine . 2014 Apr; 48(2):718-9. PMID: 24711221
No abstract available.
18.
Mazziotti G, Bianchi A, Porcelli T, Mormando M, Maffezzoni F, Cristiano A, et al.
J Clin Endocrinol Metab . 2013 Jun; 98(8):3402-10. PMID: 23771918
Context: Cross-sectional studies showed an elevated prevalence of vertebral fractures in acromegaly. However, no data are available on incident vertebral fractures in this clinical setting. Objective: The objective of the...
19.
Iacovazzo D, Bianchi A, Lugli F, Milardi D, Giampietro A, Lucci-Cordisco E, et al.
Endocrine . 2013 Jan; 43(2):452-7. PMID: 23325364
Double pituitary adenomas represent up to 2.6 % of pituitary adenomas in large surgical series and up to 3.3 % of patients with Cushing's disease have been found to have...
20.
Nasto L, Fusco A, Colangelo D, Mormando M, Di Giacomo G, Rossi B, et al.
Eur Rev Med Pharmacol Sci . 2012 Oct; 16(9):1227-34. PMID: 23047507
Background: Osteoporosis is a very common bone disorder and accounts for 1.4 million vertebral compression fractures (VCFs) per year, mostly in post-menopausal women. Aim: The aim of this study was...